There were 2,372 press releases posted in the last 24 hours and 431,896 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FDA approves retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image